CN Creative (or Intellicig as we know them), a healthcare company providing solutions to reduce smoking and smoking-related illnesses, has raised a Series A financing round led by Advent Life Sciences. The financing raised 2 million pounds (US $3.1 million).
CNC intends to use the investment to continue and finalise development of its Nicadex™ electronic inhaler nicotine replacement therapy (NRT) product for use as part of medically supervised smoking cessation programmes.
They intend to file for UK MHRA approval of the Nicadex™ Inhaler Nicotine Replacement Therapy in 2012 with regulatory filings in the US and globally thereafter.
About two years ago, I remember when the estimated cost of licensing an e-cig for medical use was reckoned by those in the know to be less than £200k. Now we know it's a fair amount more.
peHUB » CN Creative Raises Series A
CN Creative Raises Series A Funding to Develop First Medically Approved Electronic Inhaler... -- MANCHESTER,.England, Jan. 25, 2012 /PRNewswire/ --
CN Creative was established in 2008 by David Newns and Chris Lord.
It sells Intellicig in 26 countries and offers other services including QuitDirect, which provides smoking cessation mentoring.
The firm employs 40 staff across its headquarters and research facility in Manchester and sales and warehouse operations in Accrington.
Revenues in the 12 months to last September were £1.75m. Mr Newns said he expects the figure to rise to £2.6m this year. He said staff numbers are on track to reach 100 within three years.
CNC intends to use the investment to continue and finalise development of its Nicadex™ electronic inhaler nicotine replacement therapy (NRT) product for use as part of medically supervised smoking cessation programmes.
They intend to file for UK MHRA approval of the Nicadex™ Inhaler Nicotine Replacement Therapy in 2012 with regulatory filings in the US and globally thereafter.
About two years ago, I remember when the estimated cost of licensing an e-cig for medical use was reckoned by those in the know to be less than £200k. Now we know it's a fair amount more.
peHUB » CN Creative Raises Series A
CN Creative Raises Series A Funding to Develop First Medically Approved Electronic Inhaler... -- MANCHESTER,.England, Jan. 25, 2012 /PRNewswire/ --
CN Creative was established in 2008 by David Newns and Chris Lord.
It sells Intellicig in 26 countries and offers other services including QuitDirect, which provides smoking cessation mentoring.
The firm employs 40 staff across its headquarters and research facility in Manchester and sales and warehouse operations in Accrington.
Revenues in the 12 months to last September were £1.75m. Mr Newns said he expects the figure to rise to £2.6m this year. He said staff numbers are on track to reach 100 within three years.
Last edited: